Qualigen Therapeutics (NASDAQ:QLGN) Trading Up 1% – Here’s What Happened
by Renee Jackson · The Cerbat GemQualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report)’s share price traded up 1% on Thursday . The company traded as high as $1.06 and last traded at $1.05. Approximately 10,264 shares traded hands during trading, a decline of 99% from the average daily volume of 1,521,488 shares. The stock had previously closed at $1.04.
Qualigen Therapeutics Trading Up 1.0%
The firm has a market cap of $1.78 million, a price-to-earnings ratio of -0.14 and a beta of 0.24. The company’s 50-day moving average is $1.28 and its 200-day moving average is $1.53.
Qualigen Therapeutics Company Profile
Qualigen Therapeutics, Inc (NASDAQ: QLGN) is a life sciences company headquartered in Westminster, Colorado, that combines immunodiagnostic reagents with novel immuno-oncology therapies. Operating through two primary business units—Qualigen Diagnostic Solutions and Qualigen BioTherapeutics—the company seeks to leverage its expertise in antibody engineering and assay development to address both clinical laboratory needs and unmet medical needs in oncology.
Through its Qualigen Diagnostic Solutions division, the company designs, manufactures and distributes immunoassay reagents, kits and related consumables for use in clinical and research laboratories.